PDA Journal of GMP and Validation in Japan
Online ISSN : 1881-1728
Print ISSN : 1344-4891
ISSN-L : 1344-4891
Topics Review
Drafting Process and key Points of ICH Q2(R2) and Q14 Guideline (2)
Yukio HIYAMA
Author information
JOURNAL FREE ACCESS

2021 Volume 23 Issue 2 Pages 45-52

Details
Abstract

This article describes the drafting process and key points of ICH Q2(R2)(Analytical Validation) and ICH Q14(Analytical Development). The harmonization effort started in 2018 and the two documents are being drafted by one Expert Working Group. The drafts for public consultation will be published in early 2022. The revised Q2 will include spectroscopic procedures, procedures used for biologics, multivariate analysis based procedures, etc. The new Q14 will cover Enhanced (Quality by Design) development approach. Q14 emphasizes that the enhanced knowledge supports robust analytical procedures and their effective lifecycle management.

Content from these authors
© 2021 Parenteral Drug Association Japan Chapter
Previous article Next article
feedback
Top